MedWatch

Bavarian Nordic: Vaccine production almost came to Denmark

According to VP for Investor Relations & Communications Rolf Sass Sørensen, the Danish pharmaceutical company came close to landing its first partial production contract for covid-19 vaccines on Danish soil.

Photo: Philip Davali/Ekstra Bladet, Philip Davali

The Danish company Bavarian Nordic was close to establishing parts of an actual production for filling covid-19 vaccines in Denmark, according to the Vice President for Investor Relations & Communications Rolf Sass Sørensen.

Since spring, it has been a top priority for the Danish government to start Denmark-based vaccine production.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

"Real world" patient data documents the long-term effects of ALK vaccines

In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers. 

Further reading

Related articles

Latest news

See all jobs